Cardiotoxicity | Timing | Demographic | Source | Affected substrate |
Doxorubicin | Early | Adult | Anthracycline | Cardiomyopathy |
Late | Paediatric | Anthracycline | Cardiomyopathy | |
Carfilzomib | Acute | Adult | VEGF | Hypertension |
PD1/PDL1 | Late | Adult | Immune | Myocarditis |
PD1, programmed cell death-1; PDL1, programmed death-ligand 1 VEGF, vascular endothelial growth factor.